Surgery – Controlled release therapeutic device or system
Reexamination Certificate
2001-05-11
2004-08-10
Thanh, Loan H. (Department: 3763)
Surgery
Controlled release therapeutic device or system
Reexamination Certificate
active
06773428
ABSTRACT:
FIELD OF THE INVENTION
The invention relates to devices for managing erectile dysfunction and more specifically to an implantable device for delivering pharmacologic agents into the cavernosal body.
BACKGROUND OF THE INVENTION
Erectile dysfunction, which is the persistent inability to attain and maintain penile erection sufficient for intercourse, is a major health issue among males and especially among the aging male population. The causes of erectile dysfunction include vasculogenic, neurogenic, endocrinilogic and psychogenic causes. Management options for erectile dysfunction depend on the cause of the dysfunction and include medical and surgical therapies and vacuum erection devices, each with their own limitations and complications.
Medical therapies include the oral, transcutaneous (penile injection) and transurethral (e.g. MUSE System) routes of delivery of various pharmacologic agents. See, for example, U.S. Pat. No. 5,916,569 to Spencer et al., U.S. Pat. No. 5,925,629 to Place, and U.S. Pat. No. 6,156,753 to Doherty, Jr. et al. However, many men are not suitable candidates for oral agents such as sildenafil (Viagra; Pfizer, New York), a phosphodiesterase inhibitor, because of potential life threatening interactions with cardiac medications such as nitrates.
Penile (intracavernosal) injection therapy with vasodilator agents such as prostaglandin E
1
, papaverine, nitric oxide, phentolamine, apomorphine, or pharmacologic intestinal peptide (VIP) is a well-accepted method. The technique however must be taught to anxious patients with careful attention to the dose injection sites, and the amount of the agent. Many patients withdraw from intracavernosal injection therapy because of the anxiety associated with self-injection, recurrent cutaneous ecchymoses, painful injections, or associated corporal fibrosis (Peyronie's Disease). Moreover, patients are uncomfortable when they travel through public airports or to foreign countries with syringes and medications. These limitations, associated with the complete loss of spontaneity, are the main reasons for discontinuation in an otherwise successful pharmacologic erection program.
Surgically invasive procedures have been reserved for those men who fail conservative therapies; these options include revascularization procedures, penile prostheses and cavernous nerve stimulation devices, e.g. U.S. Pat. No. 5,938,584 to Ardito et al. and U.S. Pat. No. 6,169,924 B1 to Meloy et al. Penile prostheses are generally last resort because implantation results in irreparable damage to the nerves and musculature.
SUMMARY OF THE INVENTION
It is therefore a primary object of this invention to provide a system and method for managing erectile dysfinction that is effective, does not cause irreparable damage to the nerves and musculature, and allows for spontaneity.
It is a further object of this invention to provide a system for managing erectile dysfunction with pharmacologic agents that is implantable and refillable.
The preferred embodiment of the implantable delivery system of the invention for managing a patient's erectile dysfunction, generally comprises: one or more reservoir members adapted to be substantially implanted in the patient's scrotal pouch and to at least temporarily store one or more pharmacologic agents; one or more means for accessing and refilling one or more of the reservoir members with one or more of the pharmacologic agents; one or more distal end members comprising one or more means for dispensing at least a portion of the pharmacologic agents into one or both of the patient's cavernosal bodies; one or more means for transporting at least a portion of the pharmacologic agents from the reservoir member to the distal end member; and one or more means for causing at least a portion of the pharmacologic agents to be transported from the reservoir member to the distal end member. At least one of the means for accessing and refilling preferably comprises a self-sealing diaphragm that is capable of being punctured with a needle and is integral with the reservoir member and at least one of the means for dispensing preferably comprises one or more distal catheter members provided with one or more perforations through which one or more of the pharmacologic agents are capable of passing.
One or more of the distal catheter members may comprise a plurality of graduated perforations, from a proximal portion of the distal catheter member to a distal portion of the distal catheter member, that are adapted to facilitate distribution of the pharmacologic agents evenly within the cavernosal body; wherein one or more of the distal catheter members may further comprise an increasingly graduated inner diameter, from a proximal portion of the distal catheter member to a distal portion of the distal catheter member, that is adapted to facilitate distribution of the pharmacologic agents evenly within the cavernosal body.
The means for transporting preferably comprises one or more heparin-coated, sialastic catheters and the means for causing the agents to be transported preferably comprises, one or more pressure-sensitive valves and at least one pump member that interacts with the reservoir member to release a predetermined dose of the pharmacologic agents from the reservoir member to the means for transporting.
Another preferred embodiment of the implantable delivery system of the invention for managing a patient's erectile dysfunction, comprises: one or more reservoir members adapted to be substantially implanted in the patient's scrotal pouch and to at least temporarily store one or more pharmacologic agents; one or more means for accessing and refilling one or more of the reservoir members with one or more of the pharmacologic agents; one or more distal end members comprising one or more perforations for dispensing at least a portion of the pharmacologic agents into one or both of the patient's cavernosal bodies; one or more conduits for transporting at least a portion of the pharmacologic agents from the reservoir member to the distal end member; and one or more pumps that interact with one or more of the reservoir members to release a predetermined dose of at least a portion of the pharmacologic agents from the reservoir member into one or more of the conduits. One or more of the means for accessing and filling may comprise one or more self-sealing diaphragms.
The preferred method of the invention, for managing a patient's erectile dysfunction, generally comprises the steps of: providing an implantable delivery device, comprising, one or more reservoir members that is provided with a self-sealing diaphragm and adapted to be substantially implanted in the patient's scrotal pouch and to at least temporarily store one or more pharmacologic agents, one or more distal end members comprising one or more perforations for dispensing at least a portion of the pharmacologic agents into one or both of the patient's cavernosal bodies, one or more conduits for transporting at least a portion of the pharmacologic agents from the reservoir member to the distal end member, and one or more pumps that interact with one or more of the reservoir members to release an effective amount of at least a portion of the pharmacologic agents from the reservoir member into one or more of the conduits; surgically implanting the device so that, at least one of the reservoirs is implanted in the patient's subdartos scrotal pouch so that the diaphragm can be accessed with a needle; and at least one of the distal end members is implanted subtunically in at least one of the patient's corpus cavernosal bodies; filling at least one of the reservoirs with one or more of the pharmacologic agents by puncturing the diaphragm with a needle containing the pharmacologic agents and injecting the pharmacologic agents into the reservoirs; activating the pump to release the pharmacologic agents into the conduit to allow the released pharmacologic agents to be transported and dispensed into at least one of the cavernosal bodies
Haeckl, Esq. Jenifer E.
Mirick O'Connell DeMallie & Lougee LLP
LandOfFree
Implantable delivery system and method for the pharmacologic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Implantable delivery system and method for the pharmacologic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Implantable delivery system and method for the pharmacologic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3276618